Dosage and administration
· Cleanse targeted skin area, pat dry. · Apply a thin layer to the affected area, not more than 3–4 times daily.
· Cleanse targeted skin area, pat dry. · Apply a thin layer to the affected area, not more than 3–4 times daily.
· Store at 15–30°C (59–86°F) · Protect from excessive heat and direct sunlight · Use only as directed
Lidocaine 4% (w/w)
External analgesic
· Temporarily relieves pain and itching due to:
minor burns, sunburn, insect bites, scrapes, minor skin irritations.
For external use only.
· on large areas of the body.
· on broken, blistered, or abraded skin.
· if allergic to local anesthetics such as lidocaine, benzocaine, or other "caine" derivatives.
· avoid contact with the eyes
· do not bandage tightly or use with heating pad
· use only as directed
· Condition worsens or does not improve within 7 days.
·Allergic reaction occurs to ingredients in this product.
· Symptom being treated does not subside or if redness, irritation.
· Condition worsens or does not improve within 7 days.
·Allergic reaction occurs to ingredients in this product.
· Symptom being treated does not subside or if redness, irritation.
If swallowed, get medical help or contact a poison control center right away.
· Cleanse targeted skin area, pat dry.
· Apply a thin layer to the affected area, not more than 3–4 times daily.
· Store at 15–30°C (59–86°F)
· Protect from excessive heat and direct sunlight
· Use only as directed
Aqua, Glycerin, Isopropyl Palmitate, Aloe Barbadensis Leaf Extract,
Helianthus Annuus (Sunflower) Seed Oil, Glyceryl Stearate,
Pentylene Glycol, Cetyl Alcohol, Piper Methysticum Leaf/Root/Stem Extract, Peg-100 Stearate, Tocopheryl Acetate, Panthenol, Camellia Japonica Flower Extract,
Zingiber Officinale (Ginger) Root Extract, Commiphora Myrrha Extract, Camphor, Menthol, Lecithin.
| Class | Version | Type | Effective |
|---|---|---|---|
| LIDOCAINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 070fbed5-7088-434a-a7ce-f2a64d8d40ac | Product name | 2 | 20260107 |
| bee66ce1-adb7-9d3b-67d9-582e4c54e80f | Product name | 5 | 20250819 |
| 860a93dc-4863-49cc-b284-6bbe8191bc48 | Product name | 4 | 20250214 |
| eaba870a-6a9d-442e-8643-87b3f558a451 | Product name | 1 | 20250117 |
| 9b4cf230-fd05-41d5-98c6-5db9ecb27b86 | Product name | 1 | 20230117 |
| 7d755fa1-1087-4dcd-98f0-6d4bba479a57 | Product name | 3 | 20210602 |
| aed701d5-9c75-dfaf-7154-cde46179faea | Product name | 9 | 20200313 |
| fa8b5901-e681-426f-82fe-54f6d81ec698 | Product name | 4 | 20180619 |
| 332d03e4-aa24-4b11-841a-02bf41081920 | Product name | 1 | 20171221 |
| c08ab52f-2fc8-4409-9d9f-ed8edc0bd070 | Product name | 1 | 20171221 |
| 68ed98f8-24c2-44a0-944a-6d36e82ce25a | Product name | 1 | 20141222 |
| 1cd42bc2-a430-c72b-636d-991b235fbf80 | Product name | 1 | 20140508 |
| 49fa150c-f0de-cce7-3d9c-993ed81c5698 | Product name | 1 | 20140508 |
| 4d7ae718-ed00-bae8-2abe-9eaec1eef7ff | Product name | 1 | 20140508 |
| 9137811f-f279-8640-5aeb-99fa2145d64d | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 85817-003-01 | Aouiv 4% Lidocaine Numbing Cream | 60 g in 1 BOTTLE | CREAM | 60 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 85817-003 | 85817-003-01 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Aouiv 4% Lidocaine Numbing Cream | 4% LIDOCAINE NUMBING CREAM | Guangzhou Qiexiran Cosmetics Co., Ltd. | 3a221dd2-e945-bd0e-e063-6294a90a8fb9 | 2025-07-17 | Warnings | 85817-003-01 85817-003 85817000301 3a221dd2-e946-bd0e-e063-6294a90a8fb9 3a221dd2-e945-bd0e-e063-6294a90a8fb9 |
Adverse event summaries are temporarily unavailable. Other product information remains available.